Her experience spans prescription and consumer health, medical technology and not-for-profit organizations, and saw her working with leading health companies, including Bayer, GE, GSK, Janssen, Jenny Craig, Pfizer and Sanofi. Before joining WE, she established Haystac’s national health care offering, which she ran for four years, and spent time at Edelman and Burson Marsteller. She has spent the past eight years at WE, most recently as CEO of Australia. Hudson is a seasoned health communications expert with over two decades’ experience across PR and medical education programs. “Her wealth of sector knowledge and client leadership experience makes her the ideal leader to propel our health team’s growth and development in Australia, and regionally.” “Gemma is an exceptional global health leader and has been instrumental in developing the agency’s health practice in Australia and leading international, cross-market client relationships within the agency’s network,” said Rebecca Wilson, executive vice president, Singapore & Australia, WE. Under her new purview, Hudson is charged with accelerating sector growth opportunities and cementing the agency’s health sector proposition in Australia and across the Asia Pacific region. SYDNEY - 1 MARCH 2021 - WE Communications (WE), a leading independent global integrated communications firm, today announced Gemma Hudson as executive vice president of Health Innovation and Growth. GEMMA HUDSON ASSUMES NEWLY CREATED ROLE AS THE AGENCY FURTHER EXPANDS ITS HEALTH PARTNERSHIPS
0 kommentar(er)
